Brainstorm Cell Therapeutics Inc. (BCLI)

BCLI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7	6	13	13	60	145
Market Cap Growth	42.96%	-52.87%	-3.18%	-77.69%	-58.70%	1.59%
Enterprise Value	8	7	14	15	57	123
Last Close Price	0.66	0.55	2.27	4.09	24.60	60.00
PB Ratio	-0.73	-0.61	-1.67	-2.75	-19.88	7.50
P/TBV Ratio	-	-	-	-	-	7.51
Debt / Equity Ratio	-0.12	-0.12	-0.13	-0.26	-1.36	0.26
Net Debt / Equity Ratio	-0.11	-0.11	-0.11	0.01	-0.37	-0.88
Net Debt / EBITDA Ratio	-0.12	-0.12	-0.07	0.00	-0.04	0.70
Net Debt / FCF Ratio	-0.16	-0.16	-0.09	0.00	-0.06	0.64
Quick Ratio	0.01	0.01	0.03	0.17	0.35	3.51
Current Ratio	0.03	0.03	0.04	0.24	0.35	3.69
Return on Equity (ROE)	-	-	-	-	-297.38%	-89.25%
Return on Assets (ROA)	-435.92%	-435.92%	-241.99%	-211.70%	-82.24%	-38.09%
Return on Capital Employed (ROCE)	99.70%	99.70%	163.60%	596.90%	7112.30%	-106.90%
Earnings Yield	-142.08%	-168.91%	-89.78%	-128.57%	-40.51%	-16.85%
FCF Yield	-	-114.30%	-70.23%	-153.13%	-32.29%	-18.33%
Buyback Yield / Dilution	-84.58%	-84.58%	-74.87%	-17.99%	-0.91%	-21.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.